China Health Industries Holdings, Inc. (CHHE) Debt to Equity (2016 - 2024)
China Health Industries Holdings (CHHE) has disclosed Debt to Equity for 14 consecutive years, with -$0.01 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Debt to Equity fell 110.49% year-over-year to -$0.01, compared with a TTM value of -$0.01 through Mar 2024, down 110.49%, and an annual FY2022 reading of $0.16, down 12.48% over the prior year.
- Debt to Equity was -$0.01 for Q1 2024 at China Health Industries Holdings, up from -$0.02 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.18 in Q1 2020 and bottomed at -$0.02 in Q4 2023.
- Average Debt to Equity over 5 years is $0.14, with a median of $0.18 recorded in 2020.
- The sharpest move saw Debt to Equity increased 3.84% in 2021, then crashed 111.39% in 2023.
- Year by year, Debt to Equity stood at $0.18 in 2020, then increased by 3.84% to $0.18 in 2021, then dropped by 26.81% to $0.13 in 2022, then crashed by 111.39% to -$0.02 in 2023, then rose by 6.0% to -$0.01 in 2024.
- Business Quant data shows Debt to Equity for CHHE at -$0.01 in Q1 2024, -$0.02 in Q4 2023, and $0.14 in Q1 2023.